undefined undefined undefined

Ask the Trialists - NEO-MINDSET

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session type: Ask the Trialists

Access

Like

Getting ahead of the curve with early and intensive lipid-lowering strategies for acute coronary syndrome prevention: an interactive case-based challenge

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session type: Satellite Symposium

Access

Like

For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?

Event: ESC Congress 2024

Topic: Acute Coronary Syndromes

Session type: Satellite Symposium

Access

Like

HOT LINE 4

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Hot Line

Access

Like

Improving cardiorenal outcomes in type 2 diabetes

Event: ESC Congress 2023

Topic: Diabetes and the Heart

Session type: Symposium

Access

Like

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy?

Event: ESC Congress 2021 - The Digital Experience

Topic: Peripheral Vascular and Cerebrovascular Disease

Session type: Great Debates

Access

Like

Controversies in Antiplatelet Treatment: Is Short-Term Dual Antiplatelet Therapy Safe and Effective after PCI?

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session type: Debate Session

Access

Like

Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium - Experts on the Spot

Access

Like

Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Access

Like

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Access

Like

undefined undefined undefined

Contributor content

Ask the Trialists - NEO-MINDSET

Getting ahead of the curve with early and intensive lipid-lowering strategies for acute coronary syndrome prevention: an interactive case-based challenge

For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?

HOT LINE 4

Improving cardiorenal outcomes in type 2 diabetes

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy?

Controversies in Antiplatelet Treatment: Is Short-Term Dual Antiplatelet Therapy Safe and Effective after PCI?

Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

ESC 365 is supported by